Residual Cardiovascular Biomarkers After Medical Therapy and Their Prognostic Implications Following Percutaneous Coronary Intervention.

Saved in:
Bibliographic Details
Title: Residual Cardiovascular Biomarkers After Medical Therapy and Their Prognostic Implications Following Percutaneous Coronary Intervention.
Authors: Cho JH; Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea., Ahn JH; Cardiovascular Centre, Gyeongsang National University Changwon Hospital, Changwon and Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea., Kang MG; Division of Cardiology, Gyeongsang National University Hospital and Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea., Bae JS; Cardiovascular Centre, Gyeongsang National University Changwon Hospital, Changwon and Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea., Koh JS; Division of Cardiology, Gyeongsang National University Hospital and Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea., Jung MK; Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea., Kim SW; Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea., Gorog DA; Faculty of Medicine, National Heart and Lung Institute, Imperial College, London and Centre for Health Services Research, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom., Tantry US; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, Maryland, USA., Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, Maryland, USA., Kim W; Cardiovascular Department of Internal Medicine, Kyung Hee University Hospital, Seoul, South Korea., Hwang JY; Division of Cardiology, Gyeongsang National University Hospital and Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea. Electronic address: angiojoy@gmail.com., Jeong YH; CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, South Korea. Electronic address: goodoctor@naver.com.
Source: JACC. Advances [JACC Adv] 2026 Feb; Vol. 5 (2), pp. 102498. Date of Electronic Publication: 2026 Jan 02.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-963X
DOI:10.1016/j.jacadv.2025.102498